Health Care [ 10/12 ] | Health Care Equipment & Supplies [ 50/73 ]
NASDAQ | Common Stock
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally.
It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium.
The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage.
It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures.
In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators.
AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jul 15, 25 | -0.03 Increased by +50.00% | -0.12 Increased by +75.00% |
| Apr 2, 25 | 0.03 Increased by +118.75% | -0.13 Increased by +123.08% |
| Jan 8, 25 | -0.04 Increased by +20.00% | -0.11 Increased by +63.64% |
| Oct 3, 24 | -0.11 Increased by +8.33% | -0.15 Increased by +26.67% |
| Jul 16, 24 | -0.06 Decreased by -400.00% | -0.17 Increased by +64.71% |
| Apr 4, 24 | -0.16 Decreased by -433.33% | -0.14 Decreased by -14.29% |
| Jan 5, 24 | -0.05 Decreased by -600.00% | -0.07 Increased by +28.57% |
| Oct 4, 23 | -0.12 Decreased by -100.00% | -0.13 Increased by +7.69% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| May 31, 25 | 80.16 M Increased by +12.93% | -6.05 M Increased by +55.02% | Decreased by -7.55% Increased by +60.17% |
| Feb 28, 25 | 72.00 M Decreased by -4.23% | -4.41 M Increased by +97.65% | Decreased by -6.12% Increased by +97.55% |
| Nov 30, 24 | 72.84 M Decreased by -7.88% | -10.74 M Increased by +63.03% | Decreased by -14.74% Increased by +59.87% |
| Aug 31, 24 | 67.49 M Decreased by -14.22% | -12.80 M Decreased by -127.89% | Decreased by -18.96% Decreased by -132.52% |
| May 31, 24 | 70.98 M Decreased by -22.06% | -13.45 M Increased by +37.35% | Decreased by -18.95% Increased by +19.61% |
| Feb 29, 24 | 75.18 M Decreased by -6.85% | -187.74 M Decreased by -1.88 K% | Decreased by -249.71% Decreased by -2.02 K% |
| Nov 30, 23 | 79.07 M Decreased by -7.44% | -29.05 M Decreased by -242.30% | Decreased by -36.74% Decreased by -269.82% |
| Aug 31, 23 | 78.68 M Decreased by -3.51% | 45.88 M Increased by +452.85% | Increased by +58.32% Increased by +465.66% |